Sponsor content

TTFields: a radical new approach to cancer treatment using electric fields

Tumor-treating fields (TTFields) use electric fields tuned to specific frequencies to disrupt the division of solid tumor cancer cells. Novocure has launched Optune, its first TTFields delivery system, for the treatment of glioblastoma multiforme and potentially other solid tumor indications.

Go to the profile of Novocure
May 03, 2017
0
0
Upvote 0 Comment
Page of
Go to the profile of Novocure

Novocure

Novocure is an oncology company developing a profoundly different cancer treatment utilizing a proprietary therapy called TTFields, the use of electric fields tuned to specific frequencies to disrupt solid tumor cancer cell division. Novocure’s commercialized product, Optune, is approved for the treatment of adult patients with glioblastoma. Novocure has ongoing or completed clinical trials investigating TTFields in brain metastases, non-small cell lung cancer, pancreatic cancer, ovarian cancer and mesothelioma.

No comments yet.